Replay LSI2021 Emerging Medtech Summit
Play NowWe presented at the 2020 LSI event which led to a new (and previously non-existent) relationship with USVP. As a direct result, we just closed a $21.5M round led by USVP. A huge thank you to LSI for putting on this meeting and hosting an incredible platform that connects innovators with investors.
Fred Maxik, CSO
Healthe
Healthe is the global technology leader in developing and deploying sanitization, circadian and biological lighting solutions. These products inactivate viruses and bacteria in the air and on surfaces, regulate the body’s internal clock, boost performance and enhance sleep. Healthe’s mission is to harness the power of light to create a safer, more productive, and healthier shared environment.
Visit website.
Edward Loew, Investor Relations Officer
Vivos Therapeutics
Innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea (OSA).
Visit website.
Joseph Rafferty, CEO
VESTECK
VESTECK Suture-Tight catheter secures endovascular aortic grafts to the aorta at the time of implant or during repair procedures.
Visit website.
Jo Bhakdi, CEO
Quantgene
Quantgene is a biotechnology company focused on unlocking the deep human genome. They combine next-generation genomic sequencing, with AI and cloud technologies to innovate the future of medicine. Quantgene’s flagship product, Serenity, is a system of advanced medical intelligence using liquid biopsy, whole-exome sequencing and dynamic health profiles. Serenity medical experts use this advanced genomic technology to detect early signals of cancer and other diseases when they are easiest to treat.
Visit website.
Bill Niland, CEO
ReGelTec
ReGelTec, Inc. is a clinical stage medical device company developing the next generation of interventional spinal implants for chronic lower back pain due to degenerative disc disease. Hydrafil is a Injectable hydrogel for Degenerative Disc Disease the procedure has a very short recovery time 1-2 hrs post injection with early clinical results showing significant improvement in back pain and ODI scores.
Visit website.
Shani Bhavsar, CEO
Dash Technologies
A leader in providing Development as a Service (DaaS) for medical device start-ups, delivering programming and coding on each project basis that connects machine learning, data science, and artificial intelligence to apps, websites, existing products, or future concepts.
Visit website.
Branislav Vajdic, CEO/Founder
HeartBeam
HeartBeam developed a mHealth technology that is diagnostically equivalent to a cardiologist reading a patient’s 12 lead ECG and examining the patient.
Visit website.
James Blackledge, President/PI
Capella Imaging
Capella Imaging, Inc., is a startup biotechnology company engaged in the development of a first in class, fibrin-specific 99mTc probe (FibroScint) to be used in diagnostic procedures for the detection of thrombus, even in the presence of heavy anticoagulation. FibroScint is broadly intended for use in LVAD and RVAD mechanical circulatory support systems, intra cardiac thrombus, prosthetic valves, intravascular wires etc. for which we will pursue an Orphan Drug Indication. Evidence is also being developed that the probe could be used for diagnosis and management of pulmonary embolism (PE) and chronic thromboembolic pulmonary HTN (CETPH). The probe has the potential for detecting intravascular thrombus (coronary, carotid, peripheral vascular disease) in patients presenting with coronary syndromes, TIA/Stroke, and peripheral vascular disease.
John MacMahon, CEO
Mitre Medical
A less invasive surgical approach to treat mitral valve regurgitation (MR) in patients with moderate to severe MR.
Visit website.
Teri Sirset, CEO
Dasi Simulations
Improving the quality of care for Structural Heart Disease patients by providing innovative personalized simulations for informed pre-op preparation toward a better quality of life for people with heart disease.
Visit website.
Matt McKittrick, VP of Strategic Business Development
CytoVeris
CytoVeris is harnessing precise, smart cancer imaging solutions, by converging advanced optical imaging technologies and artificial intelligence to bring new, real-time, intraoperative cancer visualization capabilities to the operating room in order to improve the quality of cancer resections, enhance patient outcomes and reduce economic burden across the healthcare continuum.
Visit website.
Colleen Milne, Strategic Marketing
Tambre Digital Health
TAMBRE Digital Health is developing a family of wireless, smart micro-positioning orthopedic implants and software applications that collect and analyze biometric patient data throughout the course of treatment. This data enables remote patient monitoring and care post-implantation, and to generate actionable insights that can optimize treatment delivery. TAMBRE's first products will include dynamic limb lengthening devices and early onset scoliosis implants, launching a new generation of medical devices that do not exist in the market today.
Visit website.
Susan Hertzberg, CEO
BrainScope
FDA cleared non-invasive medical device that objectively assesses head injured patients for both brain bleeds & concussions at point of care
Visit website.
Dr. Kim Vanderlinden, CEO & Founder
Early Detection
Our screening test identifies a marker that is present not only in tumors, but precancerous tissue as well, which enables us to identify patients at the earliest stages, and even before the cancer has formed. Early-stage tumors can be small and so our advantage over imaging tests such as mammograms, and CTs etc., is that we do not need tumors to be a certain size. This is much more than a concept, as over 20 clinical trials have been published with over 10,000 patients. The accuracy has been outstanding, with typical sensitivity and specificity rates of 80 to 95%. The screen is safe, inexpensive, easy to conduct in an office with no equipment needed and only takes 15 minutes. Physicians and their patients will have the results before a patient leaves the office. We anticipate that this simple, easy to conduct screen will become a standard component of annual physical exams. Cancer with 600,000 US deaths is 2nd only to heart disease with 650,000 deaths. The test can screen for lung, breast, colon, prostate and uterine cancer, which accounts for approx. 1/2 of all cancer mortality.
Visit website.
Edison Hudson, CEO
Panaceutics Rx
Panaceutics Rx is building the road to economic personalized medicine integrating digital health data, robotic automation, and e-pharmacy. Its platform also incorporates innovations in patient-centric drug delivery, using single dose forms to promote daily adherence through convenience and ease of swallowing. By cost effectively making individualized combinations of the right drugs at the right doses to meet individual metabolism, the platform enables the practical use of PGx genomic and individual profile data in formulation. Edison Hudson is a serial entrepreneur and the inventor / co-founder of the platform technology and IP company Panacea BioMatx Inc, which has successfully spun-out the application of this technology to the emerging field of personalized clinical nutrition. Panaceutics Rx is a new entity formed around a professional team with expertise in running profitable 503A / B compounding and Outsourcing Pharmacies. With a solid regulatory strategy and its existing cGMP facilities, Panaceutics Rx is ready to apply its proprietary technology platform and formularies to personalized therapies of approved drugs. Making combination therapies formulated at the “N of 1” level, the on-demand systems can economically and accurately produce a patient’s monthly supply / minute on a small footprint line. While the platform is applicable to many chronic diseases, Panaceutics Rx’s will focus in the next year on the launch of poly-therapies for primary and secondary cardiovascular diseases in partnership with hospital and physician groups that have reviewed the therapies and agree that the company’s solutions will improve quality of life for their patients as well as lowering the cost of care.
Visit website.
Patrick O'Donnell, President & CEO
HD LifeSciences
HD LifeSciences is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. HD LifeSciences' proprietary, biomimetic Soft Titanium technology clearly distinguishes their products in the $1.5B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.
Visit website.
Andrew Glass, CEO
Vivasure Medical
Based in Ireland, Vivasure is a leader in advanced polymer implants and delivery systems for cardiovascular procedures. Their current product PerQseal® is designed for large hole arteriotomy closure and has obtained CE Mark. With an excellent safety profile, is the only fully bioabsorbable solution and only large hole solution that does not require any pre-procedure steps. Vivasure is also developing a pipeline of products based on their fully bioabsorbable and novel approach.
Visit website.
Chad Croasdale, President & Chief Commercial Officer
270Surgical
270Surgical is a medical device company based in Israel and the USA that is pioneering ultrawide view in minimally invasive surgery with the world’s first 270˚ field of view 4K laparoscopic system. The system also eliminates fogging and allows caregivers to see through surgical smoke.
Visit website.
Peeyush Shrivastava, CEO
Genetesis
Commercial-stage medical technology company redefining the way myocardial ischemia and coronary artery disease are clinically diagnosed and triaged by combining our noninvasive biomagnetic imaging technology with proprietary cloud-based web services and machine-learning capabilities.
Visit website.
Randall Whiting, Chief Operating Officer / Member BOD
Cephasonics Ultrasound Solutions
In the future, measuring things inside the body will be as easy as taking your blood pressure. Having precise data and measurements in real time is becoming more and more critical for the doctor and care giver while performing medical procedures and diagnosis. Cephasonics is leading the way in using AI and ultrasound data to non-invasively automatically detect, identify, characterize and measure things in the body without the need for a trained professional. Today, Cephasonics is the only company to provide a complete FDA-ready HW & SW OEM ultrasound platform that provides unfettered access to ultrasound data and enables AI for clinical applications that support medical procedures and diagnosis with precise data about key aspects of a medical procedure in real time.
Visit website.
Richard Vincent, CEO
FundamentalVR
Accelerating surgical capability for life science businesses via precision VR simulation.
Visit website.
Yuval Mandelbaum, CEO
DisCure Medical
DisCure Medical developed a minimally invasive device designed to reverse Degenerative Disc Disease, a condition associated with >35% of all Low Back Pain cases. The technology targets the underlying cause of the disease, eliminating pain and restoring the disc’s normal function via a breakthrough electric approach.
Visit website.
Mark Forchette, President & CEO
Delphinus Medical Technologies
The patented technology is a 3D whole breast ultrasound imaging device that delivers no radiation, requires no compression, and images the entire breast with a single scan.
Visit website.
Krassen Dimitrov, CEO
MAVIDx
Our molecular diagnostics platform is designed and developed to significantly scale current infectious disease diagnostic capacity around the world.
In addition to massive scale, it delivers simple workflow and proven accuracy at a low cost which uniquely positions it for mass testing (COVID-19, Influenza A, B, RSV) and surveillance of large populations.
Visit website.
Jacques Petit, CEO
Monatomics Technology
Monatomics Technology is a development stage company pioneering a novel inhalable gas mixture consisting of xenon, helium, oxygen and administered by a respiratory system that reduces neurotoxicity and thereby the risk of disability in acute ischemic stroke patients.
Visit website.
Chris Jung, CEO
FluidIQ
The HOPE InVent is a low-cost, rapidly manufacturable (via 3D printing), deployable ventilator that can be used in areas of need where ventilators are scarce, unavailable, or are impractical (because of resource deplete and harsh environments or due to limited supplies of standard ventilators).
Visit website.
Anna Lisa Somera, CEO
Rhaeos
Noninvasive thermal sensor for use in the monitoring of ventricular shunt function.
Visit website.
Joe Urban, CEO
Potrero Medical
A predictive health company developing the next generation of medical devices with smart sensors and artificial intelligence.
Visit website.
Shyam Natarajan, CEO
Avenda Health
Transforming whole gland prostate cancer therapy into a targeted, office based lumpectomy to preserve quality of life -- made patient-specific with AI.
Visit website.
Michael Nagel, President & CEO
Vomaris Innovations
Bioelectric technology that has the potential to revolutionize infection control and wound healing.
Visit website.
Howard Walthall, Founder & CEO
Lumiheal Therapeutics
Lumiheal Therapeutics is harnessing the power of fluorescent light energy to heal chronic and acute wounds, burns and surgical incisions. Our mission is to make highly effective advanced wound therapies affordable and accessible to all.
Visit website.
Sahil Diwan, CEO
SafKan Health
OtoSet® is the first automated and FDA Cleared ear cleaning device for clinical use, which will be available to healthcare professionals soon. A consumer version for home use is also in development.
Visit website.
Eric Ryan, President & CEO
Provisio Medical
Provisio Medical is working to revolutionize endovascular procedures through the development of Sonic Lumen Tomography, a novel intravascular ultrasound technology that provides accurate and precise real-time flow lumen dimensions. Without the shortcomings of low-resolution angiogrphy's ionizing radiation and kidney-toxic contrast media, Provisio's SLT IVUS platform looks to seamlessly provide physicians the exact information that they need, when they need it, to improve both clinical workflows and outcomes.
Visit website.
Susan Trent, CEO
Atlantic Therapeutics
Technology to treat the root cause of female incontinence.
Visit website.
Alberto Rodriguez-Navarro, CEO
Levita Magnetics
Our innovative magnetic surgical platform, called Magnetic Surgery®, is the next step in the evolution of less invasive surgery.
Visit website.
Ed Ellsworth, Director of Global Regulatory Affairs & US Business Development
Nuralogix
A different kind of AI. Using a conventional video camera, the cloud-based Affective AI engine can detect and measure a wide variety of human affects that take the form of physiological and psychological states.
Visit website.
John Timberlake, President & CEO
Berkshire Biomedical
A revolutionary virtual care and prescription drug management system designed to become the standard-of-care in personalized medication delivery.
Visit website.
Daniel Hawkins, CEO
Avail Medsystems
Pioneering procedural telemedicine. For remote industry support, clinical education, and remote proctoring, the Avail System was purposefully built to enable procedure collaboration.
Visit website.
Ben Bobo, Co-Founder President & CEO
Retriever Medical
Peripheral venous clot management
Visit website.
George Aliphtiras, CEO
Sonic Incytes Medical
Velacur is a portable, handheld ultrasound that integrates machine learning to enhance image guidance, resulting in a confident assessment of liver health in all body types.
Visit website.
Eric Dy, CEO
Bloomlife
Improving the health and wellbeing of women and their babies through personalized prenatal care. Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health.
Visit website.
Patrick Treacy, CEO
Onkos Surgical
Onkos Surgical delivers high quality implants and instruments that meet the unique needs of musculoskeletal tumor patients.
Visit website.
Vlad Hogenhuis, Head of Business Development
GATT Technologies
Novel game changing synthetic platform of very fast, strong adhesive and cost effective hemostatic and sealant products, outperforming standard of care. Target indications include full surgical spectrum, starting with liver, cardio-vascular and soft tissue. Clinical stage for first product as per April 21, CE mark target 22, FDA 23, followed by multiple additional pipeline products.
Visit website.
Sam Shah, CEO & Chairman
Long Term Care Operations 360
Long Term Care Operations 360, Inc. (LTCO) is a Minority run business. Our goal and passion is to provide quality care for seniors by applying technology solutions to ensure compliance with state and federal requirements so our employees can devote their time to care instead of paperwork. Our centers have been recognized by Georgia Governor, Secretaries of State and the President of the United States for the good will they create in the community. LTCO handle both the technology aspects and the operational aspects of ADH centers, Home Care Services including skilled and unskilled nursing, Home Delivered Meals and non-emergency medical transportation.
Visit website.
Brian Kannard, CEO
PercuSense
PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment.
Visit website.
David Muller, CEO
Allotex
Allotex Inc. is an ophthalmic biologics and device company developing new therapeutic solutions for the treatment of presbyopia, hyperopia, and myopia.
Visit website.
Nelson Patterson, CEO
Anavasi Diagnostics
Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average. Anavasi has received NIH funding through the RADx program for COVID-19 diagnosis, and was a semi-finalist in the XPrize COVID-19 diagnostics competition. Anavasi will complete its EUA clinical trial in April 2021 and expects to start commercialization Q2 2021 upon FDA authorization. We are seeking interested investors and strategic partners.
Yair Brosh, CEO
Donisi Health
The Donisi system identifies changes in cardiopulmonary health status to deliver personalized, predictive insights that support early detection of congestive heart failure. Donisi developed only clinically validated contact-free device that can identify pulmonary congestion & eight other cardiopulmonary bio parameters. Donisi’s innovative technology has won multiple international awards, is backed by 26 registered patents, and is currently undergoing the FDA certification process (expected Q1 2021). The system consists of an in-home, contact-free, non-invasive cardiac and pulmonary sensing unit + health cloud + API enabled sync with app or care provider platform. The system maintains accuracy from a distance, is unaffected by layers of clothing or ambient lighting conditions and has been installed in homecare and assisted living care providers in the US & Israel.
Visit website.
Sergio Aguirre, CEO
EchoPixel
EchoPixel’s True 3D is the first interactive mixed reality software platform for improved surgical imaging that facilitates more precise and personalized surgical planning.
Visit website.
Ashutosh Shastry, CEO
Evanostics
A Silicon-Valley-based start-up founded by engineers and toxicologists with a mission to save human lives and improve patient care by simplifying diagnostics—making it easy, fast and accurate. Evanostics’ vision is to “create the thermometer” for diagnostic testing.
Visit website.
Pete DeAngelis, CEO
TrakPoint Solutions
TrakPoint Solutions offers the most accurate, lowest cost and most scalable indoor asset tracking (RTLS) system for healthcare, retail and industrial markets.
Visit website.
Marc Zemel, CEO
Retia Medical
AI that empowers radiology teams. The first-in-kind, end-to-end, radiology quality management platform via a novel approach of comparing “vision” and “text” for discrepancies.
Visit website.
John McDermott, CEO
Vascular Therapies
A biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring an AV fistula for dialysis.
Visit website.
Lloyd Diamond, CEO
Pixium Vision
Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.
Visit website.
Olivier Delporte, CEO
Miracor Medical
Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO). A novel first-line therapy used during PCI to positively change the course for Acute MI patients.
Visit website.
M. Victoria Reade, COO
Vita Imaging
Novel, Raman spectroscopy based medical device for skin cancer screening and diagnosis
Visit website.
Khalil Bitar, Founder/CEO
CELLF-BIO
Regenerative medicine-based therapies for common functional digestive disorders, repairing and reinstating function through cell-made innovations.
Visit website.
Aviel Blumenfeld, CEO
IMedis
AI that empowers Radiology teams. IMedis is on a mission to create a comprehensive quality management platform for Radiology departments using groundbreaking AI technology.
Visit website.
Joseph McGinley, CEO
McGinley Orthopaedic Innovations
The IntelliSense Drill is an innovative handheld robotic technology which can change the standard of care in orthopedic procedures.
Visit website.
Tim Swift, CEO
Roam Robotics
Advancing robotic exoskeleton technology to meet the needs of not only the military and performance athletes, but people with osteoarthritis in everyday life.
Visit website.
David Jenkins, Founder & Chairman
Catheter Precision
VIVO™ (Catheter Precision, Inc.), is a novel non-invasive localization device. It uses propriety software and standard clinical inputs (ECG, MRI/CT) to generate a patient specific cardiac model and to identify the location(s) where a ventricular arrhythmia originates. VIVO provides a safe (FDA Cleared) pre-procedural map to provide information for the physician to assist in reducing procedure times and increasing procedural accuracy and efficacy.
Visit website.
Anthony Mooz, Data Scientist & Founder
Age-Less AI
AGE-LESS AI is developing remote patient monitoring, clinical biomarkers, dashboards, and cloud-based software for neurological disorders by accurately tracking health measurements and symptom management using non-invasive real-time machine learning.
Visit website.
Ran Poliakine, CEO
Nanox Imaging
A digital X-ray source enabling a cost reduction of imaging systems by orders of magnitude. Planning a mass deployment of imaging systems to drive early detection preventive healthcare as a new standard of care.
Visit website.
Michael Peck, CEO
Patheous Health
Patheous Integrated Dysphagia Care (iDC) helps seniors and senior care providers diagnose and treat the dysphagia episode of care through the coordinated use of our patented remote patient monitoring technology, mobile imaging diagnostics, evidence-base therapeutic applications and nutrition coaching applications.
Visit website.
Josh Butters, CEO
Synergy Disc Replacement
The first artificial disc that has been designed to restore physiological motion and correct sagittal balance.
Visit website.
Kerry Pope, CEO
Crystalline Medical
Forward-viewing, image-guided interventional system that seeks to significantly improve both the safety and efficacy of millions of procedures per year in the areas of cardiology, interventional radiology, interventional oncology, and emergency medicine.
Visit website.
Amir Jafri, CEO
Immunicom
Redefining the limits of immunotherapy through the development of innovative, non-pharmaceutical treatment approaches for cancer, inflammatory diseases, and autoimmune diseases.
Visit website.
John McCutcheon, CEO
EBR Systems
Superior treatment for millions of patients suffering from cardiac rhythm diseases by developing safe, clinically superior, cost-effective and reliable therapies using wireless cardiac stimulation.
Visit website.
Don Stewart, CEO
PlantForm
Focused on the rapid development and production of specialty antibody and protein drugs using our proprietary vivoXPRESS® platform. The plant-based vivoXPRESS® system makes it easier, faster and less expensive to produce approved biologic drugs for novel indications and new markets.
Visit website.
Jay Cormier, President & CEO
Eyedaptic
Visual aid software, enabled by augmented reality hardware, for macular degeneration and other retinal diseases. The software goes beyond magnification to enable a fuller field of vision, and simulates natural vision for those suffering from central vision disorders such as AMD (age-related macular degeneration), to revitalize their quality of life.
Visit website.
Angus McLachlan, CEO
Liberate Medical
The VentFree Respiratory Muscle Stimulator uses proprietary non-invasive neuromuscular electrical stimulation to contract the abdominal wall muscles in synchrony with exhalation during mechanical ventilation.
Visit website.
Ash Attia, CEO
Bionic Vision Technologies
BVT Bionic Eye System, the world’s first suprachoroidal visual implant, to restore functional vision to the blind suffering from inherited retinal diseases.
Visit website.
Tom Kottler, CEO
Sonopor
A simple, novel way to treat untreatable or otherwise difficult to treat infections with its UD2™️ Ultrasonic Drug Delivery Platform, combining a proprietary ultrasound system with subcutaneous, local delivery of existing antibiotics, creating new anti-infective treatments with therapeutic advantages and minimal side effects.
Visit website.
Mark Toland, CEO
MMI
Enhancing surgical performance through a robotic system that enables surgeons to achieve better outcomes in microsurgery. The Symani Surgical System combines proprietary innovations including the world’s smallest wristed micro instruments as well as tremor reducing and motion scaling technologies.
Visit website.
Dan Myers, CEO
MediPrint Ophthalmics
Harnessing the power of the MediPrint™ process to print drug layers on FDA-approved contact lenses, MediPrint™ Ophthalmics uses its proprietary technology to develop contact lenses that provide sustained drug delivery of medications for ocular disease.
Visit website.
Jim Kasic, CEO
EndoShape
Minimally invasive medical devices for peripheral vascular and neuro vascular uses in the interventional radiology market that will substantially replace existing technology.
Visit website.
Aly Elbadry, CEO
CloudCath
Remote monitoring platform for catheter-based treatments. CloudCath’s first served population is End Stage Renal Disease (ESRD) patients that are on Peritoneal Dialysis (PD).
Visit website.
Matthieu De Beule, CEO
FEops
Predictive, personalized computational modeling and simulation solutions for structural heart interventions that empower medical device manufacturers to bring superior products faster to the market and enable physicians to improve clinical outcomes.
Visit website.
Wayne Markman, CEO
SYMBYX
SYMBYX is the first company in the world to trial and demonstrate success in managing Parkinson’s disease and Fibromyalgia symptoms in humans with non-pharmaceutical therapies. SYMBYX is developing light therapies, using both laser and LED light, to modify microbial colonies in the gut and mouth in order to reduce inflammation and metabolise dopamine and serotonin - two critically deficient neuro-chemicals in most people with Parkinson’s (PWP). SYMBYX therapies have recently achieved CE Marking and TGA (Australia) approval and we will be targeting FDA approval next. Various metabolic diseases, including Irritable Bowel, are a probable next focus as well Autism Spectrum Disorder (ASD, all of which have significant gut-brain linkages.
Visit website.
Laurence Marsteller, CEO
Radiance Therapeutics
Next-generation beta ophthalmic applicator.
Visit website.
Peter Bloch, CEO
BresoTEC
Innovative devices using proprietary acoustic and accelerometer technology to diagnose sleep apnea.
Visit website.
Albert Huang, Founder/CEO
Allotrope Medical
Enhancing surgical precision through safe electrical stimulation.
Visit website.
Tim Boire, CEO
VenoStent
Developing bioengineered smart polymers to transform vascular surgery.
Visit website.
John Murphy, CEO
Virtual Incision
The company is developing the MIRA® (Miniaturized In vivo Robotic Assistant) Platform, a first-of-its-kind miniaturized surgical robotic support device, focusing first on colon resection, with follow-on specialty robots for additional potential applications.
Visit website.
Daniel Powell, CEO
Spark Biomedical
Transcutaneous Auricular Neurostimulation (tAN™) for opioid withdrawal relief.
Visit website.
Lloyd Mencinger, President & CEO
Aqua Medical
Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy.
Visit website.
K.C. Hoos, co-founder & COO
EDGe Surgical
Single-use electronic depth gauge with superior measurement capabilities, optimized hook design and easy-to-read digital display that aims to improve accuracy, precision, and speed of these measurements while eliminating the risk of infection associated with reusable devices in orthopedic surgical procedures.
Visit website.
Moufeed Kaddoura, CEO
Kenota Health
Bringing advanced testing technologies to the field of medicine, revolutionizing the way physicians test for and treat diseases.
Visit website.
Anand Sheel, CEO
Terapede Systems
Ultra-high resolution medical flat panel X-ray detector with a 40% lower dose.
Visit website.
Brian Thornes, CEO
X-Bolt Trauma
Innovative devices for hip fixation and long bone nailing.
Visit website.
Kareen Looi, CEO
Pedra Technology
Non-invasive, deep tissue, real-time tissue perfusion monitor for use in peripheral angioplasty and vascular surgery.
Visit website.
Alan Sage, CEO
Vaporox
Improving lives by healing wounds and saving limbs, Vaporox was formed to commercialize Vaporous HyperoxiaTherapy(VHT™). VHT is a patented and FDA-510K-cleared technology that represents a breakthrough in treating 7 different types of skin wounds, including diabetic foot ulcers (DFUs) and pressure ulcers (bedsores).
Visit website.
Jeff Levine, Founder/CEO
Advanced Scanners
Operating at the Intersection of Machine Vision and Digital Surgery, we aim to take the guesswork out of 23+ Million hospital-based procedures.
Visit website.
Don Wright, President & CEO
Clarigent Health
Helping save lives with enhanced listening. Patented AI identifies vocal biomarkers that signal potential suicidal risk, supporting clinical decisions and workflow efficiency.
Visit website.
Reinhard Krickl, CEO
Phagenesis
Transforming the lives of people with dysphagia, using revolutionary treatments developed through a commitment to scientific and clinical excellence.
Visit website.
John Ashley, CEO
DurVena
Treatment for saphenous vein grafts that strengthens the graft and reduces the intimal hyperplasia that leads to graft failure. This treatment address three large unmet clinical markets, CABG, PAD, and AVF.
Peter Boyd, CEO
Sonnest
Developing a voltage-activated, ultrasound imaging agent that will allow clinicians to assess and monitor myocardial perfusion of the heart at the bedside, in real-time using traditional ultrasound techniques.
Visit website.
Molly Wade, Founder & CEO
Barologics
Disruptive technology to treat hypertension, heart failure and CKD through closed loop stimulation of Hering’s nerve.
Carol Burns, President & CEO, Co-Founder
Cagent Vascular
Treating atherosclerotic disease with the first and only serration balloon technology to restore blood flow.
Visit website.
Nadine Haram, Founder & CEO
Proximie
A secure, complete software solution which expands surgical collaboration enabling surgeons to share expertise using augmented reality tools before, during and after surgery.
Visit website.
Adam Sachs, CEO
Vicarious Surgical
Transforming surgery through robotics and virtual reality.
Visit website.
Ashok Khandkar, CEO
Elute
A new class of polymer-controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections.
Visit website.
Bill Perry, CEO
Deep Blue Medical Advances
Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. Additional products in development include an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh.
Visit website.
Kevin Richardson, Chairman & CEO
SANUWAVE
A shockwave technology company developing patented, noninvasive devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.
Visit website.
Jong Lee, CEO & Cofounder
Day Zero Diagnostics
Day Zero Diagnostics uses whole genome sequencing and machine learning to modernize infectious disease diagnosis and treatment. DZD is developing a rapid diagnostic for sepsis that uses genomic data to identify a pathogen and to comprehensively profile its antibiotic resistance, as well as services for hospital infection control. Our goal is modernize hospital microbiology using NGS and a big-data approach.
Visit website.
John VeLure, President & CEO
i-Lumen Scientific
A novel surface neurostimulation technology (called Neural Retinal Therapy™) to restore vision in those afflicted with Dry, Age-related Macular Degeneration (or Dry AMD).
Visit website.
Brian Hutchison, Executive Chairman and CEO
Catalyst OrthoScience
Catalyst OrthoScience develops and markets surgical implants that make orthopedic surgery less invasive and more efficient for both surgeons and patients. The company's first offering, the Catalyst CSR Total Shoulder System, represents the next evolution in total shoulder arthroplasty.
Visit website.
Ziad Rouag, CEO
BIOMODEX
BIOMODEX uses 3D printing to create tissue-like anatomical twins from medical images. The anatomically accurate twins are designed to provide critical tactile and imaging feedback to users which, when paired with simulated blood flow stations, offers a unique and tailored end to end physician experience.
Visit website.
Peter Van Haur, CEO
VitalConnect
Reimagining a world with predictive health at our fingertips.
Visit website.
Bruce Lichorowic, President & CEO
Galen Robotics
Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures.
Visit website.
Dushyanth Surakanti, CEO
Sparta Biomedical
The first osseointegrative biomimetic knee cartilage implant.
Visit website.
Harlee Sorkin, CEO
InterShunt Technologies
Proprietary catheter system that allows for the capture and excision of tissue from the interatrial septum. The result is a left to right atrial shunt that off-loads elevated left atrial pressure, reducing symptoms in Heart Failure patients. The mechanical system is designed for safety and ease of use and is the only interatrial shunting device that requires no implant and no energy.
Visit website.
Ken Coffey, CEO
AtriAN Medical
Long-term, non-thermal resolution of atrial fibrillation.
Visit website.
Gabriel Sanchez, CEO
Enspectra Health
Enspectra Health (formerly Zebra Medical Technologies) is developing a novel system to image live cellular anatomy without cuts or stains. We aim to transform patient care across multiple conditions, beginning with the detection and treatment of skin cancers.
Visit website.
John Zak, President & CEO
XaTek
As a platform technology, the ClotChip™ device from XaTek is a handheld, point-of-care global assay to evaluate the hemostatic process. The ClotChip is agnostic to the cause of any defect of coagulation and is therefore uniquely situated to serve urgent needs of a number of different clinical markets.
Visit website.
Debbie Teodorescu, MD, Founder
SurgiBox
SurgiBox is an ultraportable sterile field that fits in a backpack.
Visit website.
Matt Miller, Director Of Technology Development
Genesis Software Innovations
Genesis Software Innovations, GSI, was formed to develop innovative and integrated software tools focused around orthopedic surgical centers.
Visit website.
Todd Moseley, CEO
Spinal Simplicity
Innovative, simple solutions for complex spinal problems.
Visit website.
Cody Simmons, CEO
DermaSensor
DermaSensor, Inc. enables all medical professionals to effectively check for skin cancer. The DermaSensor device is an affordable handheld tool that uses artificial intelligence and spectroscopy to evaluate skin lesions for cancer in a matter of seconds.
Visit website.
Vadim Gurevich, CEO
GLW Medical Innovation
GLW is an innovation-driven, commercial-stage, orthopedic technology company focused on developing radiolucent implants and creative manufacturing solutions. Amalgamating the strength of titanium with a unique blend of polyetheretherketone (PEEK) or PEEK with reinforced carbon fiber (CFR PEEK), our manufacturing process for orthopedic implants creates a highly efficient production output at a significantly lower cost. These groundbreaking see-through implants avoid radiographic opacity and scatter, allowing surgeons to assess success and healing with greater ease. Combined with efficient manufacturing and low-cost production, our current commercialization goals offer a competitive alternative in an ever-changing healthcare environment.
Visit website.
Jerry Mezger, President & CEO
Harbor MedTech
A fully integrated, commercial-stage regenerative medicine company. Two FDA-cleared and CE marked products and a broad pipeline that leverage a patented BriDGE® technology. The BriDGE® Process transforms standard type-1 collagen into a bio-friendly, stabilized collagen matrix which acts as a trigger to activate the patient’s own healing cascade.
Visit website.
Andrew McDaid, Founder & CEO
OPUM Technologies
Automated care platform for knee health. OPUM’s intelligent platform utilizes AI to provide actionable data and insights help you to manage recovery and long-term knee health.
Visit website.
Bradley Paddock, President & CEO
CeQur
CeQur is commercializing advanced, simple-to-use insulin delivery devices that make it easier for people living with diabetes to adhere to therapy and stay in control of their disease. The Company’s simple, three-day, wearable devices provide freedom from multiple daily insulin injections.
Visit website.
Angela Liedler, Chairman and CEO
Precisis
Neurostimulation for cortical functional impairments.
Visit website.
Renee Ryan, CEO
Cala Health
A bioelectronic medicine company transforming the standard of care for chronic disease.
Visit website.
Claude Nogard, CEO
Ergosuture
Surgical solutions that help improve suturing safety, speed and versatility.
Visit website.
Dr Arnaud Rosier, Founder & CEO
Implicity
Implicity is a digital MedTech that develops an AI-powered platform to remotely monitor patients with connected pacemakers and defibrillators, and a medical grade software that aims to improve cardiac care and optimize medical teams efficiency.
Visit website.
Clark Tedford, President & CEO
LumiThera
Developing photobiomodulation treatments for ocular diseases and disorders.
Visit website.
Jeffrey Weisberg, CEO
ChipCare
Multiplexed point-of-care diagnostics for sexually transmitted infections. Utilizing a patented approach for analyte detection, the platform can perform multiple classes of assays including cell surface markers, proteins and nucleic acids from an easily collected sample such as urine.
Visit website.
Keith Carlton, CEO
EBT Medical
Disruptive neuromodulation technologies focused on pelvic floor disorders.
Visit website.
Bob Radie, Chairman & CEO
Neuraptive Therapeutics
Therapeutics product designed for administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves. Also developing a suite of advanced microsurgical instruments for use in peripheral nerve surgery.
Visit website.
Christopher Kent, President & CEO
ODS Medical
AI-enabled optical detecion systems for tumor margin assessments.
Visit website.
Susan Wood, President & CEO
VIDA
VIDA is transforming lung care through intelligence, using imaging-based AI to uniquely profile and manage the patient with or at-risk of respiratory diseases.
Visit website.
Ted Bird, Chief Strategy Officer
Dymicron
Dymicron is an innovation-driven medical technology company that is advancing a new generation of musculoskeletal devices made from Polycrystalline Diamond (PCD)—one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use in all human interbody applications.
Visit website.
Ali Bakhshinejad, CEO
VasoGnosis
An Artificial Intelligence Powered diagnostic and surgical planning Software as a Service for cerebrovascular diseases.
Visit website.
David Kuraguntla, CEO
Alio (fka GraftWorx)
Alio (San Francisco, CA) is an early commercial stage company who believes it is time we tap into the opportunity to revolutionize today’s tools for remote patient monitoring. The technologies in the current market are invasive, expensive, often provide inadequate data and do not deliver a positive user experience. Re-imagining what care looks like for those facing dialysis and heart failure has been done before, but the execution has failed. We understand chronic conditions do not merely require episodic care, but rather reliable and clinically accurate remote patient monitoring seamlessly integrating itself into a patient’s day to day life.
Visit website.
Nikhil Shah, CEO & Co-Founder
Nephrodite
Developing and commercializing our fully implantable continuous dialysis device - The Holly.
Visit website.
Dr. Ben Lipps, CEO and Chairman
Magforce
Nanotechnology-based therapy for the treatment of cancer.
Visit website.
Manny Villafaña, PhD, Sc, Founder of St. Jude Medical, ATS, Cardiac Pacemakers
Medical 21
Developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.
Visit website.
Benjamin Holmes, CEO
Nanochon
Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3-D printing to create an implant which can permanently repair debilitating joint injuries. The implant can bear loads like a traditional joint implant, quickly restoring a patient’s movement.
Visit website.
Alan Lucas, CEO & Founder
Navigation Sciences
Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement.
Visit website.
Joseph Connell, Chairman
NeuEsse
Plant-based human skin substitute in either a protein material bandage or a "no-touch" application protocol device (especially for burns) that is lightweight, portable, military-grade and available at any point of injury to deliver skin substitutes along with other therapeutics for military and civilian patients.
Visit website.
Bryce Klontz, CEO
New View Surgical
New View Surgical, Inc. is an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery. Our VISIONPORT™ platform is a novel surgical visualization and access system that aims to simplify and cost-reduce the technology required to perform minimally invasive abdominal and thoracic procedures. Our mission is to increase access to minimally invasive techniques for patients around the world.
Visit website.
Stephen Merrick, CEO
NorthStar Medical
Nuclear medicine technology company committed to providing stable, domestic and environmentally friendly radioisotope supply solutions to meet the needs of patients and advance clinical research. Fundamentally transforming the ways that medical radioisotopes are produced and distributed around the world.
Visit website.
Cristian Atria, Founder & CEO
nView Medical
3D imaging in surgery using AI image creation algorithms that merge prior information with real-time data gathered during surgery to reduce imaging time and to minimize x-ray radiation.
Visit website.
Lishan Aklog, MD, Chairman & CEO
PAVmed
PAVmed Inc. is a highly differentiated, multi-product, commercial-stage medical technology company with a diversified product pipeline addressing unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. Its major subsidiary, Lucid Diagnostics Inc., markets the first and only commercial tools for widespread early detection of esophageal precancer and cancer - the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device. Its GI Health division also includes the complementary EsoCure™ Esophageal Ablation Device with Caldus™ Technology. Its Minimally Invasive Interventions markets its CarpX® Minimally Invasive Device for Carpal Tunnel Syndrome. Other divisions include Infusion Therapy (PortIO™ Implantable Intraosseus Vascular Access Device and NextFlo™ Intravenous Infusion Set), and Emerging Innovations (non-invasive laser-based glucose monitoring, pediatric ear tubes, and mechanical circulatory support).
Visit website.
Ryan Shelton, PhD, CEO & Co-Founder
PhotoniCare
The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates.
Visit website.
Bryan Lord, CEO
Pristine Surgical
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.
Visit website.
Amit Vohra, PhD, CEO
Promaxo
Next generation office-based modular MRI and MRI based technologies. Initial focus on advancing the solutions for prostate disease management and other urology and pelvic conditions.
Visit website.
Richard Hanbury, CEO
Sana Health
Non-invasive bio-therapeutic device for pain management.
Visit website.
Geoffrey Klass, CEO
Sense Diagnostics
The Sense devices is a non-invasive, disposable technology that continuously monitors brain activity primarily in the intensive care unit.
Visit website.
Berk Tas, President & CEO
SentiAR
Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.
Visit website.
Rob Ball, CEO
Shoulder Innovations
Total shoulder replacement system that addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.
Visit website.
Gabriele Grecchi, CEO & Co-Founder
Silk Biomaterials
A breakthrough technology platform which harnesses the natural properties of silk. The first application will be in nerve repair, with 510(k) clearance expected at the end of 2H20
Visit website.
Nick Delmonico, President & CEO
Strados Labs
User-friendly sensors, unique collection methodologies, and data processing software that creates a more holistic view of a patient's respiratory health.
Visit website.
Attila Borbath, CEO
Synergia Medical
Leveraging photonics to create a platform for small, safe and long-lasting neurostimulators.
Visit website.
John Barrett, CEO
ZKR Orthopedics
New procedure to mimic the clinical effects of tibial osteotomy procedures. Implants will be delivered to the proximal tibia below the patellar tendon, offloading and re-directing the tendon to reduce pain and inflammation.
Visit website.
Thomas Marchand, CEO
NIDO
NIDO (Boston, MA) is a medical device company developing SEPIA, an innovative solution for epicardial VT ablation that has been initiated by two investigators at Boston Children’s Hospital and Harvard Medical School. SEPIA will allow safe access and real-time visualization of the epicardial surface. Ultimately it will reduce complications and improve ablation efficiency, leading to decrease recurrence of VT.
Visit website.
Bob Cathcart, CEO
AiM Medical Robotics
MRI compatible robotic systems for the Neurosurgery market.
Visit website.
Claude LeDuc, CEO
Ortho Regenerative Technologies
Orthobiologics company developing novel therapeutic tissue repair device/drug/biologic combination products to dramatically improve the success rate of Orthopedic and Sports Medicine Surgeries.
Visit website.
Stuart Mitchell, PhD, Founder & CEO
Novuson
Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
Visit website.
Joseph Muldoon, CEO
FAST BioMedical
A medical technology company focused on the development of a patented technology for measuring plasma volume and kidney function.
Visit website.
John Klock, CEO
QT Imaging
QT Imaging is a privately held technology company engaged in the research, development and commercialization of an innovative automated breast imaging system producing high-resolution transmission ultrasound images.
Visit website.
Doug Daniels, CEO
Stroma Medical
STRŌMA® is the leader in permanent eye color change, with its revolutionary STRŌMA® Laser System. Its patented laser initiates a natural metabolic process that gradually eliminates the superficial pigment in darker eyes to reveal your natural underlying color.
Visit website.
Osman Khawar, CEO
Diality
Smart, flexible, portable, home hemodialysis machine that will enable patients to treat themselves wherever they are.
Visit website.
Tamer Mohamed, CEO
Aspect Biosystems
Combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics.
Visit website.
Charlie Huiner, CEO
Modulim
Optical imaging solutions powered by spatial frequency domain imaging that help clinicians assess compromised circulation.
Visit website.
Michael Whitman, CEO
Micro Interventional Devices
Micro Interventional Devices, Inc. (MID), a Delawarecorporation founded in 2010, is a development stage medical device companyfocusing on the design, manufacture and commercialization of disruptivetechnologies for use in percutaneous structural heart repair procedures. MID is currently enrolling patients in a CE Mark study in Europe.
Visit website.
Raj Reddy, President & CEO
Canary Global
Canary Global Inc. (CGI) develops the Pelican diagnostics platform which is targeted towards the point of care molecular diagnostics market. CGI is a medical technology company that unleashes the power of smart sensors and deep learning for early disease detection. Combined with AI powered intelligence, Canary’s nano-sensor technology can detect diseases, characterize the nature and location of cancers, and predict and monitor responses to therapy.
Visit website.
Philip Rackliffe, CEO
Centerline Biomedical
A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
Visit website.
William Curtis, CEO
nRichDX
An emerging leader in the liquid biopsy sample prep market, delivering to downstream molecular testing up to 75X more target material (ctDNA, CTCs, exosomes, etc.) than existing sample prep systems.
Visit website.
Atul Sharan, CEO
CellMax Life
A liquid biopsy company focused on cancer screening with a proprietary technology for detecting precancer and cancer cells in a single blood sample.
Visit website.
Per Persson, CEO
Acarix
Acoustic monitoring of coronary artery diseases of the heart. Modern tool for early and accurate CAD rule-out.
Visit website.
John Barrett, CEO
Auctus Surgical
Technology to treat pediatric scoliosis with non-fusion surgical system.
Visit website.
Nissan Elimelech, Founder & CEO
Augmedics
Advanced technologies aimed at revolutionizing surgical treatment. Initial product delivers augmented-reality head-mounted display for spine surgery which allows surgeons to see the patient’s anatomy through skin and tissue, as if they had "X-Ray Vision."
Visit website.
Kevin Rocco, CEO
Biorez
Biorez is developing bio-inductive implants for the $7B sports medicine market that help restore joint stability and help direct the healing and regeneration of new functional tissue. After the healing process is complete, our implants are naturally broken down by the body, restoring the anatomy without the chronic risks of permanent synthetic materials.
Visit website.
Randy Preston, Chief Business Officer
Centese
Transforming surgical drainage with intelligent digital devices to reduce complications and costs.
Visit website.
Mohan Frick, CEO
ChemoTech
The company is dedicated to innovation in cancer care and recently launched IQwave. This technology performs electrochemotherapy which is approved for the treatment of a wide range of tumors.
Visit website.
William Altman, CEO
CorInnova
Minimally invasive, soft robotic cardiac device creating a new paradigm for heart failure treatment.
Visit website.
Claude Cohen-Bacrie, Founder, President & CEO
e-Scopics
e-Scopics is a French startup which democratizes ultrasound imaging to all healthcare professionals. It manufactures a digital transducer and a connected software APP to provides quantitative imaging for several medical conditions. The image formation process is no longer HW based but rather a SaaS running on a cell phone, a Tablet or the Cloud, with AI based algorithms for quantitative diagnosis.
Visit website.
Jennifer Fried, CEO
ExplORer Surgical
ExplORer Surgical is a digital case support solution designed for launching innovative products and supporting complex procedures, in-person or remotely, to improve patient care and accelerate new technology adoption around the world.
Visit website.
Tej M. Singh, MD, CEO
Fist Assist
Wearable device for vein identification and enhancement for the ESRD patient.
Visit website.
Matt Kesinger, CEO
Forest Devices
ALPHASTROKE is a device to help first responders identify stroke and triage patients to the right hospital.
Visit website.
Ryan Roeder, Chief Technology Officer & Founder
HAPPE Spine
Hydroxyapatite Porous PEEK (HAPPE) is a patented biomaterial technology-platform for orthopaedic and spinal implants. No other product on the market offers the combined benefits of the bioactivity of hydroxyapatite for bone ongrowth, designed porosity for bone ingrowth, the strength of PEEK for bone-like mechanical properties, and the radiolucency of PEEK for post-operative radiographic assessment. Proprietary manufacturing capabilities further allow for unlimited implant designs, most notably for interbody spinal fusion.
Visit website.
